1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist...

38
1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials

Transcript of 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist...

Page 1: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

1CLINICAL TRIALS

Digital Pathology in Clinical Trials

Arnold B. Gelb, M.D.Senior Staff Pathologist

Quest Diagnostics Clinical Trials

Page 2: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

2CLINICAL TRIALS

Potential Conflict of Interest Statement

Employee of Quest Diagnostics Owner of stock in Quest DiagnosticsNo financial interest in any imaging company

Page 3: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

3CLINICAL TRIALS

Clinical Trials

Image Analysis

Image Analysis

Digital Archiving

Digital Archiving

AdjudicationAdjudication

Introduction Introduction

Page 4: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

4CLINICAL TRIALS

Quest Diagnostics Clinical Trials: Overview

One of the world's largest Central Laboratories, working to accelerate clinical drug development

Scientific Expertise– > 900 in-house scientists and pathologists covering all therapeutic areas– Extensive test menu and consultative capabilities– Full service Biomarkers and Anatomical Pathology capabilities

Laboratory Management– GCP/ICH operating philosophy– Extensive resources, knowledge and experience in handling and

managing clinical specimens, logistics, and data in regulatory compliant environment

Global Reach– Quest owned central lab facilities in North America, Europe, and India– Affiliate laboratories in China, Singapore, and Australia– >4,000 cities in 60 countries– >99% assays performed in-house.

Page 5: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

5CLINICAL TRIALS

Spectrumweb application

RAID

Internet

Site B

ScanScopeXT’s

DSRanalysis

algorithms

slidescanners

slidestorage

RAID

Site A

ScanScopeXT’s

DSRanalysis

algorithms

slidestorage

slidescanners

PCPC Viewing Stationsrunning ImageScope

(unlimited)

Spectrumweb application

DatacenterRAID central

database

centralservers

network connections

digital slidesfirewallsinternal networks

Redundant Fail-Safe

Server

RedundantFail-Safe Server

Digital Pathology Systems and Networks

Page 6: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

6CLINICAL TRIALS

InScape™

Page 7: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

7CLINICAL TRIALS

Layout

Page 8: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

8CLINICAL TRIALS

Case Details Page

Page 9: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

9CLINICAL TRIALS

The Digital Slide Image

Page 10: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

10CLINICAL TRIALS

•There is a toolbar at the top.

• Slide information such as the slide barcode or the slide ID can be seen in the title bar.

•Zoom tool is present

• The thumbnail and label can be turned off in the View toolbar.

Digital Slide Viewing Software

Page 11: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

11CLINICAL TRIALS

Image Analysis Window

Page 12: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

12CLINICAL TRIALS

Clinical Trials

Image Analysis

Image Analysis

Digital Archiving

Digital Archiving

AdjudicationAdjudication

Introduction Introduction

Page 13: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

13CLINICAL TRIALS

IHC Biomarkers

Over 50 assays developed and validated, including esoteric and novel markers, e.g.– Apoptosis– Cell cycle control– mTOR pathway– erbB receptor inhibition– IGF pathway– Angiogenesis– CD antigens

Page 14: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

14CLINICAL TRIALS

Quantitative Analysis of IHC Biomarkers

Identify and quantify morphology and intensity Subcellular localization – algorithm selection

– Nuclear, membranous or cytoplasmic Tissue (tumor) specific classification

– Manual selection of representative tumor regions by pathologist

– Automatic feature extraction (pattern recognition)

Enables analysis of invasive tumor from entire image

(LANL)

Page 15: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

15CLINICAL TRIALS

Image Analysis Algorithms

May need to adjust intensity of staining – Scanning typically based on % transmittance

Customize or “tune” algorithm to a laboratory’s unique staining process– Controls– Future: batch to batch “tuning”

Validation– Sufficient number of (de-identified) slides across

percentage range and intensity scores– 3 blind evaluation arms

Page 16: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

16CLINICAL TRIALS

“Tuning” Nuclear Segmentation

Original Image Normal Segmentation

Over Segmented Under Segmented

Page 17: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

17CLINICAL TRIALS

Control Slide

Page 18: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

18CLINICAL TRIALS

Validation

Image Analysis

Digital Slide Scoring

Manual Slide Scoring

Validate Algorithm Performance

Page 19: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

19CLINICAL TRIALS

pHH3

Histone H3 has a key role in the folding and inter-association of the chromatin fiber.

Phosphorylation of Histone H3, at serine-10 and -28, coincides with the induction of mitotic chromosome condensation.

H3 phosphorylation may contribute to proto-oncogene induction by modulating chromatin structure and releasing blocks in elongation.

Page 20: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

20CLINICAL TRIALS

pHH3

Digital assessment of the nuclear stain:

– Index = 13.7%

Page 21: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

21CLINICAL TRIALS

RXRA

Members of the RXR family, including RXRα, β and γ, are activated by 9-cis retinoic acid, that is expressed in both liver and kidney.

RXRα is an orphan nuclear receptor encoded on chromosome 9q34.2.

It plays roles in a variety of processes including embryonic patterning and organogenesis, cell proliferation and differentiation.

Page 22: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

22CLINICAL TRIALS

RXRA

Page 23: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

23CLINICAL TRIALS

pFOX03a

The forkhead family of transcription factors mediate signaling via a pathway involving IGF-1R, PI3K and Akt.

The gene is located on chromosome 6q21. Spliced transcript variants encoding the same protein have

been observed. In the presence of survival factors, Akt phosphorylates

FOXO3a, leading to its retention in the cytoplasm. Survival factor withdrawal leads to its dephosphorylation,

nuclear translocation, and target gene activation. Within the nucleus, it triggers apoptosis most likely by

inducing the expression of genes that are critical for cell death, such as the Fas ligand gene.

Page 24: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

24CLINICAL TRIALS

pFOX03a

Page 25: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

25CLINICAL TRIALS

pLIMK

LIMK1 and LIMK2 are serine/threonine kinases that are involved in actin cytoskeletal reorganization, cell growth regulation and tumor suppression via cofilin phosphorylation downstream of distinct Rho-dependent protein kinase signaling pathways.

Both are activated by various extracellular stimuli, including stromal cell-derived factor-1a and insulin, through activation of small GTPases and their downstream kinases, ROCK and PAK1.

Both LIMK 1 and 2 have been related to tumorigenesis and, thus, are studied in conjunction with anti-cancer therapies that target this pathway.

Page 26: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

26CLINICAL TRIALS

pLIMK

Page 27: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

27CLINICAL TRIALS

Integrins

Heterodimers composed of noncovalently associated transmembrane α and β subunits.

16 subunits yield over 20 receptors.Roles in cell adhesion, cytoskeletal

organization, and signaling.Involved in cell growth, differentiation,

migration and apoptosis.

Page 28: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

28CLINICAL TRIALS

An Integrin

Digital assessment of membrane staining component:

– 3+ cells = 54.7%– 2+ cells = 23.4%– 1+ cells = 21.9%

Page 29: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

29CLINICAL TRIALS

Clinical Trials

Image Analysis

Image Analysis

Digital Archiving

Digital Archiving

AdjudicationAdjudication

Introduction Introduction

Page 30: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

30CLINICAL TRIALS

Adjudication

Advantages of digital pathology for global clinical trials– Avoids time delays and costs of shipping slides

Read slides from different locations

– Education of satellite groups in trial host countries– Ensure high level of agreement/ consistency– Conferencing between central lab pathologist(s) and

sponsor’s study pathologist(s) or experts Fairer resolution than a simple majority or expert rule

Digital substitute for glass slides– When a clinical trial host country has export limitations – Primary diagnosis H&E (breast cancer) in progress

Page 31: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

31CLINICAL TRIALS

UNITED STATES

ARGENTINA

BRAZIL

ENGLAND

AUSTRALIA

BELGIUM

INDIA

CHINA

SINGAPORE

Clinical Trials Laboratories & Offices Affiliate Laboratories

Adjudication: Global Clinical Trials Laboratories

Page 32: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

32CLINICAL TRIALS

Adjudication - Validation

FDA– Validate as much as one can ahead of time– Awaiting completion of FDA approval process

Validation– Ideally study and tissue specific validation– Compare performance of digital to glass slides

Can compute intra- and inter-observer kappa coefficients

Page 33: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

33CLINICAL TRIALS

Clinical Trials

Image Analysis

Image Analysis

Digital Archiving

Digital Archiving

AdjudicationAdjudication

Introduction Introduction

Page 34: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

34CLINICAL TRIALS

Digital Archiving

Static images → whole slides– Third party multi-format image support– Third party information systems

Scan Types– Bright field: dry, oil– Fluorescence

Advantages– Circumvents problems of slide breakage or stain fading– Real-time access possible

Page 35: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

35CLINICAL TRIALS

Digital Archiving

Length of storage– Duration of study

On server– Long-term

Meet minimum retention requirements FDA – 5 years post application (21 CFR §58.195)

• But when is it submitted by sponsor? CAP – 10 years for glass slides Default – 15 years

Removable media/ hard drives Costs of storage tend to decrease over time

Other– Use in submission of data to FDA

Digital sides more compelling evidence than static images e.g., hepatitis C

Page 36: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

36CLINICAL TRIALS

Key Points

Image Analysis– Customize staining and algorithms– Validation– Software advances → entire-slide analysis

Adjudication– Decrease TAT– Harmonization– Conferencing

Digital Archiving– Real-time access– Long term storage– Regulatory submission

Page 37: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

37CLINICAL TRIALS

Acknowledgements

Stephanie AstrowMarc EdwardsVicki FreemanRon LuffMaribeth Raines

Page 38: 1 CLINICAL TRIALS Digital Pathology in Clinical Trials Arnold B. Gelb, M.D. Senior Staff Pathologist Quest Diagnostics Clinical Trials.

38CLINICAL TRIALS

Thank you very much for your time and attention

Arnold B. Gelb, [email protected]

(661) 799-6079